Biopharmaceutical company Kadmon Holdings has promoted Gregory Moss to become executive vice president, general counsel, corporate secretary and chief compliance officer.
According to Kadmon, Steven Gordon notified the company last week that he was resigning, effective immediately, as executive vice president, general counsel, chief administrative, compliance and legal officer and corporate secretary in order to pursue other opportunities.
Moss joined NYSE-listed Kadmon in 2012 and from 2015 until last week served as senior vice president and deputy general counsel. He has also been acting general counsel and compliance officer of MeiraGTx and remained a member of the MeiraGTx board of directors until June 2019.
Earlier in his career, Moss was a solicitor in the corporate risk practice group of law firm Gadens in Australia and at a boutique legal practice and hedge fund firm in New York.
‘Greg has been a key part of Kadmon’s senior management team for many years, including during our IPO. He has advised our board of directors and management on corporate governance and compliance matters and has provided astute counsel in connection with a number of major corporate activities, including the 2015 spinoff of our gene therapy platform into MeiraGTx,’ Kadmon CEO Harlan Waksal says in a statement.
‘Greg’s deep experience with Kadmon makes him a natural fit as general counsel. On behalf of the company and our board of directors, I welcome Greg into his new role.’
Ben Maiden
Ben Maiden is the editor-at-large of Governance Intelligence, an IR Media publication, having joined the company in December 2016. He is based in New York. Ben was previously managing editor of Compliance Reporter, covering regulatory and compliance...
